SIK2 and metastatic malignant neoplasm in the lymph nodes: Notably, the low expression level of SIK2 was positively correlated with lymph node metastasis (P < 0.0001), clinical stage (P = 0.0025), lymphatic invasion (P = 0.0055) and nerve/venous invasion (P = 0.0291; Table 1).